Press release
Pharmaceutical Excipient Market to Reach USD 1,600.0 Million by 2034 at a 5.1% of CAGR
Pharmaceutical Excipient Market
Pharmaceutical excipients play a critical role in drug development, acting as stabilizers, binders, and carriers that improve the efficacy, safety, and shelf life of medications. The increased emphasis on patient-centric drug delivery methods, such as controlled-release and targeted delivery systems, is fueling the demand for next-generation excipients. This trend is being further accelerated by the growing production of biologics, complex generics, and personalized medicines.
As the pharmaceutical industry shifts toward more sophisticated drug formulations, manufacturers are increasingly focusing on the development of multifunctional excipients that can meet regulatory standards while enhancing drug performance. The rising prevalence of chronic diseases and an aging population are also driving the need for improved drug delivery mechanisms, further supporting the growth of the excipient market.
The pharmaceutical excipient market is expected to witness continued growth opportunities as industry stakeholders, including pharmaceutical companies and research organizations, prioritize innovations in drug formulation. With regulatory agencies encouraging the adoption of quality-by-design (QbD) approaches, the demand for high-performance excipients is projected to rise significantly over the next decade.
Request a Sample of this Report Now: https://www.futuremarketinsights.com/reports/sample/rep-gb-932
Key Takeaways:
The pharmaceutical excipient market is expected to grow from US$ 972.9 million in 2024 to US$ 1.6 billion by 2034, at a CAGR of 5.1%.
Growth is driven by the increasing adoption of advanced drug delivery systems, biologics, and patient-centric drug formulations.
Excipients play a crucial role in enhancing the stability, bioavailability, and effectiveness of drug formulations.
Regulatory support for quality-by-design (QbD) approaches and the rise in personalized medicines are creating new growth opportunities for pharmaceutical excipient manufacturers.
Key Market Drivers
Increasing Demand for Generic and Biologic Drugs: The rising production and consumption of generic medications and biologics are driving the demand for pharmaceutical excipients, which play a crucial role in drug formulation.
Growth of the Pharmaceutical Industry: An expanding pharmaceutical sector, particularly in emerging markets, is contributing to the increased need for excipients that enhance drug delivery and stability.
Rising Geriatric Population: An aging population with a higher prevalence of chronic diseases requires more medications, thereby increasing the demand for effective excipient solutions.
Technological Advancements: Innovations in excipient formulations, including multifunctional excipients that can serve multiple purposes in drug delivery systems, are fostering market growth.
Regulatory Support for Drug Development: Favorable regulatory environments and initiatives aimed at accelerating drug approvals are encouraging investments in excipient research and development.
Challenges
Stringent Regulatory Frameworks: The complex regulatory landscape can pose challenges for manufacturers seeking to introduce new excipients or formulations into the market.
High Development Costs: The costs associated with developing new excipients can be significant, potentially limiting opportunities for smaller companies.
Competitive Landscape in the Pharmaceutical Excipient Market
The pharmaceutical excipient industry is highly competitive, with newer entrants looking to distinguish themselves with novel products. On the other hand, established players are looking to expand production facilities to meet production targets.
One of the prominent companies in the market, Ashland Global Holdings, is looking to expand its portfolio with the help of biologics. As the company's drug delivery focus enhances, even greater attention is being paid to excipients. Croda International, meanwhile, is looking to increase its functional excipients portfolio.
Recent Developments
In October 2023, India-based Clariant Chemicals announced plans to launch three new excipients as part of its VitiPure range.
In September 2023, United States-based Colorocon introduced its titanium dioxide (TiO2)-free Opadry film coating system for tablets to stop moisture from affecting them.
In November 2021, French-based Gattefossé launched three new pharmaceutical excipients, named Labrafac MC60, Gelucire 59/14, and Emulfree Duo.
Key Companies in the Pharmaceutical Excipient Market
Ashland Global Holdings
Croda International
BASF SE
Lubrizol Corporation
Evonik Industries AG
Associated British Foods
Roquette Feres
Archer Daniels Midland Company
DuPont
Avantor Performance Materials, Inc.
The Dow Chemical Company
FMC Corporation
Evonik Industries
Lubrizol Corporation
Roquette
Colorcon, Inc.
Key Segments
By Type:
Organic Chemicals
Oleochemicals
Fatty Alcohols
Mineral Stearates
Glycerin
Other Oleochemicals
Carbohydrates
Sugars
Actual Sugars
Sugar Alcohols
Artificial Sweeteners
Cellulose
Microcrystalline cellulose
Cellulose ethers
Carboxymethyl cellulose (CMC) and croscarmellose sodium
Cellulose esters
Starch
Modified Starch
Dried Starch
Converted Starch
Petrochemicals
Glycols
Povidones
Mineral Hydrocarbons
Acrylic Polymers
Other Petrochemical Excipients
Proteins
Other Organic Chemicals
Artificial
Calcium Phosphate
Metal Oxides
Halites
Calcium Carbonate
Calcium Sulphate
Other Artificial Chemicals
Other Chemicals
By Technique:
Fillers & Diluents
Suspending & Viscosity
Coating
Binders
Flavoring & Sweeteners
Disintegrants
Colorants
Lubricants & Glidants
Preservatives
Emulsifying
By Formulation:
Oral Formulations
Tablets
Capsules
Hard-gelatin Capsules
Soft-gelatin Capsules
Liquid Formulations
Other Oral Formulations
Topical Formulations
Parenteral Formulations
Other Formulations
By Application:
Taste Masking
Stabilizers
Modified-Release
Solubility & Bioavailability Enhancement
Others
By Region:
North America
Latin America
Europe
South Asia
East Asia
Oceania
Middle East and Africa (MEA)
Explore FMI's Related Ongoing Coverage on Healthcare Market Insights Domain:
Focused Ultrasound System Market -https://www.futuremarketinsights.com/reports/focused-ultrasound-system-market
MRI-Safe Neurostimulation Systems Market - https://www.futuremarketinsights.com/reports/mri-safe-neurostimulation-systems-market
Multi-channel Remote ECG Monitors Market -
https://www.futuremarketinsights.com/reports/multi-channel-remote-ecg-monitors-market
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware - 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Pharmaceutical Excipient Market to Reach USD 1,600.0 Million by 2034 at a 5.1% of CAGR here
News-ID: 3795934 • Views: …
More Releases from Future Market Insights
Workstation Software Market to Soar to USD 43.9 Billion by 2035, Fueled by 3D Mo …
Rising Demand for Workstation Software Across Industries
The global workstation software market is set for robust growth, driven by increasing demand for advanced visualization, simulation, and design tools across industries such as manufacturing, architecture, media, and entertainment. Valued at USD 14.8 billion in 2025, the market is projected to reach USD 43.9 billion by 2035, registering a compound annual growth rate (CAGR) of 11.5%. This surge reflects the rising complexity of…
Bean Flour Market Set for Robust Growth in the USA at 6.27% CAGR Through 2035
The global bean flour market is entering a period of remarkable expansion, driven by surging demand for plant-based nutrition and gluten-free alternatives. Analysts forecast the market to grow from USD 5,075.3 million in 2025 to USD 9,262.0 million by 2035, reflecting a CAGR of 6.2%. This trajectory highlights an unparalleled opportunity for manufacturers to address evolving consumer preferences while enhancing sustainability and profitability.
As the world shifts towards cleaner diets and…
Blueberry Ingredient Market Set to Soar with 6.27% Growth in the USA by 2035
The blueberry ingredient industry has firmly established itself as a cornerstone of the functional foods, nutraceuticals, and natural flavoring sectors. Analysts project the market valuation to reach approximately USD 2.8 billion by 2025, with a robust CAGR of 6.5% forecasted from 2025 to 2035. This growth is being fueled by the escalating demand for clean-label products, plant-based formulations, and functional solutions across the food, beverage, and cosmetic industries.
Click Here for…
Activated Cake Emulsifier Market Set for 6.27% Growth in the USA, Poised to Tran …
The activated cake emulsifier market is entering a transformative phase, driven by evolving consumer preferences toward premium, high-quality bakery products. Estimated to reach USD 1,343.2 million in 2025, the market is projected to achieve USD 2,360.5 million by 2035, representing a robust 5.8% CAGR over the next decade. This growth offers a strategic opportunity for manufacturers to meet rising consumer demands while future-proofing operations through innovation, regional customization, and sustainability.
Click…
More Releases for Pharmaceutical
Metronidazole Market 2023 Latest Innovations and Outlook By Players - Hongyuan P …
The Metronidazole Market 2023 study focuses on a global evaluation of information from the most recent market developments. The purpose of MarketsandResearch.biz is to offer the company's customers a comprehensive market overview to formulate development plans.
Designing of the report is done with the help of infographics, charts, and graphs. The report initially analyzes the various segments of the global Metronidazole market in a brief manner, which includes product types, applications.…
Hyperthyroidism Treatment Market Analytical Overview and Future | Merck, Herbran …
The Hyperthyroidism Treatment market research report is proficient and top to bottom research by specialists on the current state of the industry. This statistical surveying report gives the most up to date industry information and industry future patterns, enabling you to distinguish the items and end clients driving income development and benefit. It centres around the real drivers and restrictions for the key players and present challenge status with development…
Mevastatin Market Is Booming Worldwide |Zhejiang Hisun Pharmaceutical, Guangdong …
Global Mevastatin Market Size research report 2022 offers in-depth assessment of revenue growth, market definition, segmentation, industry potential, influential trends for understanding the future outlook and current prospects for the market. This study provides information about the sales and revenue during the historic and forecasted period of (2022 to 2028). Understanding the segments helps in identifying the importance of different factors that aid market growth. Estimations about the CAGR value for…
Global Specialty Pharmaceutical Market Driving Future Growth on Specialty Pharma …
Global Specialty Pharmaceutical Industry Synopsis:
The Specialty Pharmaceutical Market report provides a detailed analysis of this business space. The market is analyzed in terms of production as well as consumption. Based on the production aspect, the report includes particulars pertaining to the manufacturing processes of the product, alongside revenue and gross margins of the respective manufacturers.
The Global Specialty Pharmaceutical Market will reach xxx Million USD in 2020 with CAGR xx%…
Metronidazole Market to 2023 (+5% CAGR Expected) Top Player Profiles – Hongyua …
Metronidazole is an antibiotic and antiprotozoal medication, with the chemical formula C6H9N3O3 of can be used either alone or with other antibiotics to treat pelvic inflammatory disease, endocarditis, and bacterial vaginosis among others. Metronidazole is white crystalline powder, which can also be called as Fragyl Orvagil, Trichazol, Metronid, etc.
Get Sample Copy of this Report @ https://www.bigmarketresearch.com/request-sample/2724380?utm_source=Anil&utm_medium=OPR
Scope of the Report:
This report focuses on the Metronidazole in global market, especially in…
Metronidazole Market by Top Key Participant Hongyuan Pharmaceutical, Yinhe Aarti …
Metronidazole is an antibiotic and antiprotozoal medication, with the chemical formula C6H9N3O3 of can be used either alone or with other antibiotics to treat pelvic inflammatory disease, endocarditis, and bacterial vaginosis among others. Metronidazole is white crystalline powder, which can also be called as Fragyl Orvagil, Trichazol, Metronid, etc.
Get Sample Copy of this Report @ https://www.researchbeam.com/global-metronidazole-2018-by-manufacturers-regions-type-and-application-forecast-to-2023-market/request-sample?utm_source=Anil
Scope of the Report:
This report focuses on the Metronidazole in global market, especially in North…
